Welcome to LookChem.com Sign In|Join Free
  • or
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(phenoxycarbonyl)hydrazine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

217320-08-6

Post Buying Request

217320-08-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

217320-08-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 217320-08-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,7,3,2 and 0 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 217320-08:
(8*2)+(7*1)+(6*7)+(5*3)+(4*2)+(3*0)+(2*0)+(1*8)=96
96 % 10 = 6
So 217320-08-6 is a valid CAS Registry Number.

217320-08-6Downstream Products

217320-08-6Relevant academic research and scientific papers

Thiolysable prodrugs of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine with antineoplastic activity

Shyam, Krishnamurthy,Penketh, Philip G.,Loomis, Regina H.,Sartorelli, Alan C.

, p. 609 - 615 (1998)

Several 2-alkoxycarbonyl- and 2-aryloxycarbonyl- 1,2-bis(methylsulfonyl)-1-(7-chloroethyl)hydrazines, conceived as thiolysable prodrugs of 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, were synthesized and their antineoplastic activity evaluated against the L1210 leukemia in mice. In addition to producing 'cures' of mice bearing this tumor, many of the analogues were preferentially activated by glutathione (GSH) and/or glutathione S-transferase (GST), making them potentially useful in the treatment of multidrug resistant tumors with increased intracellular levels of GSH and/or GST.

N,n-bis(sulfonyl)hydrazines useful as antineoplastic agents

-

, (2008/06/13)

The present invention relates to a compound of the formula wherein R1 and R2 are selected from lower alkyl groups having 1-6 carbon atoms, substituted or unsubstituted aryl groups, and unsaturated alkyl groups having 1-6 carbon atoms; R3 is a substituted or unsubstituted lower alkyl group having 1-6 carbons; and R4 is selected from substituted or unsubstituted lower alkyl groups having 1-6 carbon atoms, substituted or unsubstituted aryl groups, and unsaturated alkyl groups having 1-6 carbon atoms. The present invention also relates to a pharmaceutical composition comprising the above compound, as well as a method of treating tumor cells with the compound.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 217320-08-6